Research into Acute lymphoblastic leukemia spans multiple therapeutic approaches and trial phases.

14 total trials for this combination

Showing top 10 of 14 trials

Trials

NCT ID	Title	Status	Phase
NCT05334069	Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection	RECRUITING	—
NCT00075725	Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	COMPLETED	PHASE3
NCT01142427	Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	COMPLETED	—
NCT02003222	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia	ACTIVE_NOT_RECRUITING	—
NCT00103285	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	COMPLETED	PHASE3
NCT02003222	Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia	ACTIVE_NOT_RECRUITING	—
NCT00557193	Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	COMPLETED	PHASE3
NCT03007147	Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia	ACTIVE_NOT_RECRUITING	PHASE3
NCT00720109	Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	COMPLETED	PHASE2/PHASE3
NCT01190930	Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma	ACTIVE_NOT_RECRUITING	PHASE3

Related Pages

All Acute lymphoblastic leukemia trials All trials in Green Bay, United States